Ian Karp | SVP, IR and Corporate Communications |
Dr. John Leonard | CEO |
Dr. David Lebwohl | Chief Medical Officer |
Dr. Laura Sepp-Lorenzino | Chief Scientific Officer |
Glenn Goddard | CFO |
Maury Raycroft | Jefferies |
Joon Lee | Truist Securities |
Rick Bienkowski | SVB Leerink |
Xiaobin Gao | Barclays |
Luca Issi | RBC |
Liisa Bayko | Evercore ISI |
Yanan Zhu | Wells Fargo |
Dae Gon Ha | Stifel |
Timur Ivannikov | Raymond James |
Jay Olson | Oppenheimer |
Silvan Tuerkcan | JMP Securities |
Good morning and welcome to the Intellia Therapeutics Third Quarter 2021 Financial Results Conference Call. My name is Drew and I will be your conference operator today.
Following formal remarks, we will open the call up for a question-and-answer session. This conference is being recorded at the Company's request and will be available on the Company's website following the end of the call.
As a reminder, all participants are currently in listen-only mode.